Dual-pathway complement modulation
Mini-CR1 down-regulates both the alternative and classical complement pathways, addressing multiple drivers of inflammation implicated in GA.
2
Complement Therapeutics is a clinical-stage biotechnology company developing novel therapies for complement-driven diseases.
Complement Therapeutics GmbH
Sternstrasse 21
80538 Munich
Germany
Complement Therapeutics Ltd
Central Working White City
Translation and Innovation Hub
84 Wood Lane
London, W12 0BZ
United Kingdom
Complement Therapeutics Ltd
LabG16
Stevenage Bioscience Catalyst
Gunnels Wood Rd,
Stevenage SG1 2FX
United Kingdom